New-onset diabetes mellitus associated with use of protease inhibitor.

作者信息

Eastone J A, Decker C F

出版信息

Ann Intern Med. 1997 Nov 15;127(10):948. doi: 10.7326/0003-4819-127-10-199711150-00017.

DOI:10.7326/0003-4819-127-10-199711150-00017

PMID:9382376

Abstract

摘要

相似文献

New-onset diabetes mellitus associated with use of protease inhibitor.

Ann Intern Med. 1997 Nov 15;127(10):948. doi: 10.7326/0003-4819-127-10-199711150-00017.

Diabetes mellitus associated with protease inhibitor use.

Eur J Clin Microbiol Infect Dis. 1999 Sep;18(9):675-7. doi: 10.1007/s100960050375.

New-onset diabetes mellitus associated with protease inhibitor therapy in an HIV-positive patient: case report and review.

CMAJ. 1999 Jul 27;161(2):161-4.

[Diabetes mellitus associated with protease inhibitors in HIV infected patients].

Rev Med Interne. 1998 Sep;19(9):675-6. doi: 10.1016/s0248-8663(99)80051-4.

Severe diabetes associated with protease inhibitor therapy.

Ann Intern Med. 1997 Nov 15;127(10):947. doi: 10.7326/0003-4819-127-10-199711150-00016.

Protease inhibitor-associated diabetes mellitus: a potential cause of morbidity and mortality.

J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):243-4. doi: 10.1097/00126334-200303010-00001.

Diabetes, protease-inhibitor link unproved: directorate.

CMAJ. 1997 Sep 1;157(5):502-3.

[Protease inhibitors connected to diabetes].

Ned Tijdschr Geneeskd. 1997 Jul 12;141(28):1405-6.

Health advisory: high blood sugar and diabetes seen in protease inhibitor users.

Crit Path AIDS Proj. 1998 Fall(No 33):31-2.

[Metabolic complications associated with use of protease inhibitors].

Ann Med Interne (Paris). 2000 Jun;151(4):278-82.

引用本文的文献

Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV - CDC Recommendations, United States, 2025.

MMWR Recomm Rep. 2025 May 8;74(1):1-56. doi: 10.15585/mmwr.rr7401a1.

Nucleoside Reverse Transcriptase Inhibitors Are the Major Class of HIV Antiretroviral Therapeutics That Induce Neuropathic Pain in Mice.

Int J Mol Sci. 2024 Aug 21;25(16):9059. doi: 10.3390/ijms25169059.

The Potential of to Ameliorate the Adverse Effects of Highly Active Antiretroviral Therapy (HAART).

Nutrients. 2022 Jul 27;14(15):3076. doi: 10.3390/nu14153076.

Diabetes and HIV.

Curr Diab Rep. 2018 Oct 8;18(11):125. doi: 10.1007/s11892-018-1076-3.

A randomized controlled trial to assess safety, tolerability, and antepartum viral load with increased lopinavir/ritonavir dosage in pregnancy.

AIDS Patient Care STDS. 2013 Nov;27(11):589-95. doi: 10.1089/apc.2013.0159. Epub 2013 Oct 19.

The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care.

Curr HIV/AIDS Rep. 2012 Sep;9(3):206-17. doi: 10.1007/s11904-012-0124-x.

Protease inhibitor-induced diabetic complications : incidence, management and prevention.

Drug Saf. 2005;28(3):209-26. doi: 10.2165/00002018-200528030-00003.

Antiretroviral treatment of maternal HIV infection.

Can Fam Physician. 2004 Jun;50:865-8.

Metabolic complications associated with HIV protease inhibitor therapy.

Drugs. 2003;63(23):2555-74. doi: 10.2165/00003495-200363230-00001.

Early versus delayed antiretroviral therapy in patients with HIV infection : a review of the current guidelines from an immunological perspective.

Drugs. 2003;63(13):1325-37. doi: 10.2165/00003495-200363130-00001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验